Bigul

Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Outcome of AGM

In continuation to our letter dated September 07, 2020, we wish to inform you that the 20th Annual General Meeting ('AGM') of the Company was held today, September 29, 2020, through Video Conferencing (VC) / Other Audio Video Means (OAVM). A total number of 54 shareholders attended the meeting. The meeting commenced at 3.00 P.M. and ended at 4.30 P.M. In this regard, please find enclosed the Summary of proceedings as required under Regulation 30, Part-A of Schedule -III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records.
29-09-2020
Bigul

Thyrocare Technologies (801.1): Buy

Investors with a short-term perspective can buy the stock of Thyrocare Technologies at current levels. The stock has been in a medium-term uptrend sin
22-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representatives of following organizations would be having con-call with us; i) Nomura Asset Management Singapore Ltd., at 11.00 A.M. on Wednesday, September 23, 2020. ii) Acacia Partners, at 03.30 P.M. on Wednesday, September 23, 2020. iii) Earnest Innovation Partners Pvt. Ltd., at 11.00 A.M. on Thursday, September 24, 2020. iv) Abakkus Asset Manager LLP, at 03.30 P.M. on Thursday, September 24, 2020. Please note that these are subject to any last minute changes.
22-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Appointment Of Mr. Arindam Haldar As Chief Executive Officer Of The Company

In continuation to our Letter dated September 10, 2020, and pursuant to the provisions of Regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, read with Schedule III of the Listing Regulations, we wish to inform you that Mr. Arindam Haldar has been appointed as the Chief Executive Officer of the Company and he has taken charge today, Monday the 14th September 2020.
14-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement Under Regulation 30 About Appointment Of Chief Executive Officer

This is to inform Mr. Arindam Haldar has been appointed as the Chief Executive Officer of the Company and he has taken charge today, Monday the 14th September 2020. Mr. Arindam Haldar holds B.Tech. (Hons.) from IIT, Kharagpur, and MBA in operatioand senior management roles. He has worked on the largest consumer brand in the country, Colgate. He was part of the start-up team of Pillsbury and he has set up & led Haagen-Dazs business in India from inception, and institutionalized the brand transformation at Sterlite Technology. Prior to joining Thyrocare, he was working as the Chief Executive Officer with a large chain of diagnostic labs for four years, where he joined as Chief Operating Officer and then became the CEO. While traditionally company has raised managerial resources organically, Mr. Arindam Haldar is the first senior executive to join the company laterally and this is to augment the bandwidth that is needed due to the sudden new growth opportunities in COVID related
14-09-2020

Thyrocare looks to fill various CXO posts to meet government regulations

Currently, Velumani is the promoter, chairman, MD and CEO of the company, while A. Sundararaju is the executive director and CFO
11-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Outcome Of Board Meeting- 10-09-2020

This is to inform you that the Board of Directors of the Company, at their meeting held today authorized the Dr A. Velumani, Chairman, to identify and appoint a suitable candidate as a professional Chief Executive Officer for the Company. The Board also authorised Dr. A. Velumani, Chairman to identify a competent candidate for the position of Managing Director, CFO, CIO, CAO, CMO and recommend to the board for approvals for terms and remuneration when a suitable candidate is identified for further approvals
10-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the representatives of Arisaig Partners would be having a Con-call (Zoom Meeting) with us, at 5.30 P.M. on Thursday, September 10, 2020. Please note that this is subject to any last minute changes.
09-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication

As required under the provisions of Companies Act, 2013 and the rules made thereunder and the provisions of Regulations 44 & 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have released an advertisement about the 20th Annual General Meeting convened to be held at 3.00 P.M. on Tuesday, September 29, 2020 through Video Conferencing (VC) / other Audio Visual Means (OAVM), announcing about dispatch of Notice and Annual Report for the FY 2019-20 to all the shareholders through mail along with detailed instruction for remote e-voting. We are submitting herewith copies of the above newspaper advertisements published in The Free Press Journal (English) and Pudhari (Marathi) on September 08, 2020. The newspaper publication has also been made available on the website of the Company at www.thyrocare.com. We request you to kindly take the same on your record.
08-09-2020
Bigul

Thyrocare Technologies Ltd - 539871 - Reg. 34 (1) Annual Report

Pursuant to the Regulation 34 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are submitting herewith a copy of the Annual Report along with the Notice of the 20th Annual General Meeting, which has already been circulated to all the shareholders through electronic mode. We request you to kindly take the same on your record.
08-09-2020
Next Page
Close

Let's Open Free Demat Account